CUE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CUE Shares Outstanding History and CUE YTD Return |
CUE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CUE Shares Outstanding History and CUE YTD Return |
CUE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
-14.44% CAGR Mouse over chart for data details
|
CUE Stock Price Chart |
About Cue Biopharma Inc |
Cue Biopharma is a clinical-stage biopharmaceutical company. Co.'s proprietary Immuno-Selective Targeting and Alteration of T Cells (Immuno-STAT) platform, enable Co. to restore health while avoiding the side effects of immune activation in the case of cancer and immune suppression in the case of autoimmune disease. Co. focused its internal resources on drug product candidates in its CUE-100 series of Immuno-STATs. The CUE-100 series uses the selectivity of the T cell receptor combined with rationally engineered interleukin 2 in context of the core Immuno-STAT framework for selective activation of targeted tumor-specific T cells to potentially address a range of cancers. We show 25 historical shares outstanding datapoints in our CUE shares outstanding history coverage, used to compute CUE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CUE market cap history over the course of time is important for investors interested in comparing CUE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CUE versus a peer is one thing; comparing CUE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CUE can fluctuate over the course of history. With this page we aim to empower investors researching CUE by allowing them to research the CUE market cap history. |
CUE Current Stock Quote |
Free CUE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CUE Share Performance |
Market Cap Peers |
Cue Biopharma (CUE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CUR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.